Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

215
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
Pneumonia IV: Management01:28

Pneumonia IV: Management

313
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

237
The pathophysiology of pneumonia involves the following steps:
237
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.1K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgie·2026
Same author

Diagnostic discordance and differential diagnoses of community-acquired pneumonia in the emergency department.

BMC emergency medicine·2026
Same author

Hermansky-Pudlak Syndrome Type 1 with pulmonary fibrosis: A case report and re-view of management.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2026
Same author

Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.

Respiration; international review of thoracic diseases·2026
Same author

Pandemic revisited: Characteristics, severity and clinical outcomes of patients hospitalized with SARS-CoV-2-infection in different periods of the pandemic.

Pneumologie (Stuttgart, Germany)·2025
Same author

[Recommendations for vaccination of adults for respiratory physicians].

Pneumologie (Stuttgart, Germany)·2025
Same journal

[Feedback conversations in postgraduate medical education : Structured feedback in anesthesiological postgraduate education at the University Medical Center Hamburg-Eppendorf -A pre-post analysis].

Die Anaesthesiologie·2026
Same journal

[International multidisciplinary consensus statement on perioperative fasting in adults].

Die Anaesthesiologie·2026
Same journal

[Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice].

Die Anaesthesiologie·2026
Same journal

Patent foramen ovale, bone cement implantation syndrome and paradoxical embolism : Case study and pathophysiological aspects.

Die Anaesthesiologie·2026
Same journal

[Muscle relaxation 2026-50 years of searching for the ideal relaxant].

Die Anaesthesiologie·2026
Same journal

[Anesthesiological management of adults with major burn injuries].

Die Anaesthesiologie·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

[Nosocomial pneumonia].

Santiago Ewig1

  • 1Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, EVK Herne und Augusta-Krankenhaus Bochum, Hordeler Straße 7-9, 44651, Herne, Deutschland. s.ewig@evk-herne.de.

Die Anaesthesiologie
|August 13, 2024
PubMed
Summary
This summary is machine-generated.

Nosocomial pneumonia, acquired ≥48 hours after hospital admission, requires prompt diagnosis and tailored antimicrobial therapy. Early re-evaluation and diagnostic work-up are crucial for managing treatment failures in these critical infections.

Keywords:
Anti-infective agentsDrug resistance, multipleHospital acquired pneumoniaTreatment failureVentilator-associated pneumonia

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.0K

Related Experiment Videos

Last Updated: Jun 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.0K

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • Nosocomial pneumonia (NP) is a significant hospital-acquired infection.
  • It affects both spontaneously breathing and ventilated patients.
  • Risk factors for multidrug-resistant pathogens (MDRP) influence initial treatment strategies.

Purpose of the Study:

  • To outline diagnostic and management guidelines for nosocomial pneumonia.
  • To emphasize the importance of microbiological cultures in guiding therapy.
  • To detail the approach to treatment failure in NP.

Main Methods:

  • Review of diagnostic criteria for NP.
  • Guidelines for microbiological sampling (tracheobronchial aspirates, bronchoalveolar lavage).
  • Principles of empirical and targeted antimicrobial therapy selection based on MDRP risk.

Main Results:

  • Initial antimicrobial treatment is guided by MDRP risk, with combination therapy favored when MDRP prevalence is high.
  • Microbiological results should guide adaptation of antibiotic treatment.
  • Mandatory standardized re-evaluation after 72 hours is essential.

Conclusions:

  • Effective management of nosocomial pneumonia hinges on timely diagnosis, appropriate microbiological investigation, and risk-stratified antimicrobial selection.
  • Treatment adaptation based on culture results and structured re-evaluation are key to improving outcomes.
  • Primary treatment failure necessitates a comprehensive diagnostic re-evaluation before further antibiotic administration.